Skip to content
EU’s plan for new pharma regulations poses challenges for industry, say experts at BIO convention
A proposal to provide the first overhaul of European Union pharma regulation in 20 years takes some positive steps but would still leave a […]
Health
Medicare confirms registry requirement for new class of Alzheimer’s drugs
A new class of Alzheimer’s drugs will be available to patients on Medicare – but only if the medicine has received “traditional approval” and
Medicare confirms registry requirement for new class of Alzheimer’s drugs Read More »
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected,
IRA means 40% reduction in new drugs over 10 years, report finds Read More »
FDA approves Pfizer’s RSV vaccine for adults over age 60
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on
FDA approves Pfizer’s RSV vaccine for adults over age 60 Read More »
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was
BIO-backed bills that would support startups passed by House Read More »
Breaking down the EU Pharmaceutical Package: What U.S. companies should know
The EU Pharmaceutical Package is a series of legislative proposals that aims to, among other things, improve access, affordability, and availability of medicinal products
Breaking down the EU Pharmaceutical Package: What U.S. companies should know Read More »
Ticking time bomb: reviving Lyme disease awareness
Along with climate change comes longer, warmer months, which means an extended tick season. With more time spent outdoors, there’s an inevitable increase in
Ticking time bomb: reviving Lyme disease awareness Read More »
Avian flu vaccine discussed by WOAH general session: the potential of a new pandemic
On May 21, the 90th Paris assembly for World Organisation for Animal Health (WOAH) announced concern over the dramatic rise in cases of avian
Avian flu vaccine discussed by WOAH general session: the potential of a new pandemic Read More »
340B legislation advances in U.S. House
Key legislation providing greater transparency and oversight into the 340B federal drug program moved forward in the U.S. House on May 25. The House
340B legislation advances in U.S. House Read More »
Are PBMs working in the interest of health care – or themselves?
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »